Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
SURMOUNT-2 SURMOUNT-2 is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study designed to evaluate the efficacy and safety of once-weekly Tirzepatide (10mg , 15mg) in adult patients with type 2 diabetes who are obese or overweight
If you experience any suspected side effects from your GLP-1 medication, you can report these through the MHRA Yellow Card Scheme
I look forward to seeing more results in the coming weeks
Enhanced metabolic health markers GLP 1 therapies support improvements in blood sugar levels, insulin sensitivity, and overall metabolic function when monitored properly
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
